Spurious Drugs Alert: Diazepam, PAN 40, and PAN-D Capsules Under Investigation
- 22 September 2025
- 1 month ago
CDSCO Panel Flags Trial Death, Seeks Causality Report from Reliance Life Sciences on EtanerRel
- 22 September 2025
- 1 month ago
94 Drug, Medical Product Batches Fail CDSCO Quality Tests in August
- 21 September 2025
- 1 month ago
Biocon Gets CDSCO Panel Nod to Import Aflibercept Injection for Eye Disorders, Phase IV Trial Mandated
- 21 September 2025
- 1 month ago
Sun Pharma Told to Limit Phase III Revefenacin Study to Triple Therapy COPD Patients
- 20 September 2025
- 1 month ago
Lupin Secures CDSCO Panel Clearance for Phase III COPD Inhaler Trial
- 19 September 2025
- 1 month ago
CDSCO, ICMR Release Standard Evaluation Protocols for Diagnostic Kits in India
- 19 September 2025
- 1 month ago
Box Warning, Dose Limits: India Set To Tighten Nimesulide Use
- 19 September 2025
- 1 month ago
CDSCO Launches Separate Online Provision for Subsequent Importers of Medical Devices, IVDs
- 19 September 2025
- 1 month ago
Recent News
Himachal notifies Resident doctor policy 2025
- 02 November, 2025
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.









